Illumina announces CEO transition plan as Francis deSouza resigns

Illumina announces CEO transition plan as Francis deSouza resigns


Francis deSouza, chief executive officer of Illumina Inc., during a panel session on day three of the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 19, 2023.

Stefan Wermuth | Bloomberg | Getty Images

Illumina on Sunday announced its board of directors has accepted the resignation of CEO Francis deSouza, just weeks after activist investor Carl Icahn failed to oust him from the biotech company.

The board of directors is searching for a new CEO and is considering both internal and external candidates, according to a release. Charles Dadswell, Illumina’s senior vice president and general counsel, will act as CEO in the interim.

DeSouza’s resignation is effective immediately, but he will stay on in an advisory capacity until July 31.

“It has been the privilege of a lifetime to serve Illumina,” deSouza said in the release. “We have made great progress together, but I believe we are still at the very beginning of the impact Illumina will have on human health by unlocking the power of the genome.”

Illumina, known for its DNA sequencing and array-based technology, has been in a heated proxy fight with Icahn, who owns a 1.4% stake in the company.

Icahn has accused Illumina’s executive management and board of poor oversight, particularly with regard to the company’s controversial $7.1 billion acquisition of cancer test maker Grail in 2021. Similarly, in an open letter to Illumina shareholders in April, Icahn accused deSouza of “desperately, hilariously and, most of all, unsuccessfully” trying to spin “decidedly mediocre” quarterly results during a press tour.

In late May, Icahn had urged shareholders to vote off deSouza and Chairman John Thompson from the nine-member board. Shareholders booted Thompson, but deSouza held onto his role until Sunday.



Source

Trump, Pfizer to announce agreement to lower Medicaid drug prices
Health

Trump, Pfizer to announce agreement to lower Medicaid drug prices

U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices […]

Read More
Stop overworking yourself before it’s too late, says Arianna Huffington. It’s no sign of success
Health

Stop overworking yourself before it’s too late, says Arianna Huffington. It’s no sign of success

Arianna Huffington has spent a lot of time thinking about the links between working hard and success, and she has come to the conclusion that there is a “collective delusion” about the positive correlation, while pervasive neglect of risks that can be literally fatal. She has spent years studying the science, but she also draws […]

Read More
Medicare Advantage enrollment expected to fall in 2026 as insurers cut back on unprofitable plans
Health

Medicare Advantage enrollment expected to fall in 2026 as insurers cut back on unprofitable plans

Advocates hold signs during a news conference on Medicare Advantage plans in front of the U.S. Capitol on July 25, 2023 in Washington, DC. Alex Wong | Getty Images News | Getty Images Medicare Advantage enrollment is poised to fall for the first time in nearly two decades, according to the Centers for Medicare and […]

Read More